Literature DB >> 4331802

The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets.

G N Brodie, N L Baenziger, L R Chase, P W Majerus.   

Abstract

Washed human platelets were incubated with 0.1-1.0 U/ml human thrombin and the effects on adenyl cyclase activity and on a platelet membrane protein (designated thrombin-sensitive protein) were studied. Adenyl cyclase activity was decreased 70-90% when intact platelets were incubated with thrombin. The T(1/2) for loss of adenyl cyclase activity was less than 15 sec at 1 U/ml thrombin. There was no decrease of adenyl cyclase activity when sonicated platelets or isolated membranes were incubated with these concentrations of thrombin. Loss of adenyl cyclase activity was relatively specific since the activities of other platelet membrane enzymes were unaffected by thrombin. Prior incubation of platelets with dibutyryl cyclic adenosine monophosphate (AMP), prostaglandin E(1), or theophylline protected adenyl cyclase from inhibition by thrombin. Incubation of intact but not disrupted platelets with thrombin resulted in the release of thrombin-sensitive protein from the platelet membrane. The rapid release of this protein (T(1/2) < 15 sec) at low concentrations of thrombin suggested that removal of thrombin-sensitive protein from the platelet membrane is an integral part of the platelet release reaction. This hypothesis is supported by the parallel effects of thrombin on adenyl cyclase activity and thrombin-sensitive protein release in the presence of dibutyryl cyclic AMP, prostaglandin E(1), and theophylline at varying concentrations of thrombin.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4331802      PMCID: PMC332932          DOI: 10.1172/JCI106800

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Studies on plasma membranes. 3. Mg2+-ATPase,(Na+-K+-Mg2+)-ATPase and 5'-nucleotidase activity of plasma membranes isolated from rat liver.

Authors:  P Emmelot; C J Bos
Journal:  Biochim Biophys Acta       Date:  1966-07-13

2.  A simple, sensitive method for the assay of adenyl cyclase.

Authors:  G Krishna; B Weiss; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

3.  Thrombosthenin M. Purification and interaction with thrombin.

Authors:  I Cohen; Z Bohak; E Katchalski
Journal:  Eur J Biochem       Date:  1969-09

4.  Adenyl cyclase activity in human platelets.

Authors:  S M Wolfe; N R Shulman
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

5.  Beta-adrenergic receptors in human platelets.

Authors:  Y H Abdulla
Journal:  J Atheroscler Res       Date:  1969 Mar-Apr

6.  Activation of skeletal adenyl cyclase by parathyroid hormone in vitro.

Authors:  L R Chase; S A Fedak; G D Aurbach
Journal:  Endocrinology       Date:  1969-04       Impact factor: 4.736

7.  Adenyl cyclase in human platelets: activity and responsiveness.

Authors:  P D Zieve; W B Greenough
Journal:  Biochem Biophys Res Commun       Date:  1969-05-22       Impact factor: 3.575

8.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

9.  Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo.

Authors:  P R Emmons; J R Hampton; M J Harrison; A J Honour; J R Mitchell
Journal:  Br Med J       Date:  1967-05-20

10.  Lipid metabolism in human platelets. I. Evidence for a complete fatty acid synthesizing system.

Authors:  P W Majerus; M B Smith; G H Clamon
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

View more
  13 in total

1.  Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments.

Authors:  D M Tollefsen; P W Majerus
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  Thrombin-induced protein phosphorylation in human platelets.

Authors:  R M Lyons; N Stanford; P W Majerus
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

3.  The effect of an inhibitor of the thrombin-fibrinogen reaction on thrombin-induced blood-platelet aggregation.

Authors:  R Flengsrud; C Eika; H Prydz
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

4.  The perturbation of thrombin binding to human platelets by anions.

Authors:  M A Shuman; P W Majerus
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

5.  Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.

Authors:  M J Droller; S M Wolfe
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

6.  Thrombin-induced platelet secretion. Further evidence for a specific pathway.

Authors:  M A Shuman; M Botney; J W Fenton
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

7.  Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons.

Authors:  M E Wheeler; A C Cox; R C Carroll
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Enhancement of platelet function by superoxide anion.

Authors:  R I Handin; R Karabin; G J Boxer
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

Authors:  T Fujimoto; S Ohara; J Hawiger
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

10.  Induction of the platelet release reaction by phytohemagglutinin.

Authors:  D M Tollefsen; J R Feagler; P W Majerus
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.